43rd J.P. Morgan Healthcare Conference Presentation Webcast
Neuren Pharmaceuticals (ASX: NEU) was pleased to participate in the 43rd Annual J.P. Morgan Healthcare Conference, held from 13 to 16 January 2025, in San Francisco.
Neuren delivered a presentation at the Conference and engaged in one-on-one meetings with investors and industry peers, showcasing its development pipeline for NNZ-2591 and robust financial growth profile from DAYBUE (trofinetide).
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Neuren Pharmaceuticals Limited. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Neuren Pharmaceuticals Limited a question about this update.